Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Robin I. J. Merkx"'
Autor:
Robin I. J. Merkx, Mark Rijpkema, Gerben M. Franssen, Annemarie Kip, Bart Smeets, Alfred Morgenstern, Frank Bruchertseifer, Eddie Yan, Michael P. Wheatcroft, Egbert Oosterwijk, Peter F. A. Mulders, Sandra Heskamp
Publikováno v:
Pharmaceuticals, Vol 15, Iss 5, p 570 (2022)
In this study, we compared the tumor-targeting properties, therapeutic efficacy, and tolerability of the humanized anti-CAIX antibody (hG250) labeled with either the α-emitter actinium-225 (225Ac) or the β--emitter lutetium-177 (177Lu) in mice. BAL
Externí odkaz:
https://doaj.org/article/d9cc433e7203440983f0235c2ff4da3e
Autor:
Daphne Lobeek, Mark Rijpkema, Luis David Jiménez-Franco, Egbert Oosterwijk, Andreas Kluge, Robin I. J. Merkx, Mark Konijnenberg, Peter F.A. Mulders
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 48, 3277-3285
European Journal of Nuclear Medicine and Molecular Imaging, 48, 10, pp. 3277-3285
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 48, 10, pp. 3277-3285
European Journal of Nuclear Medicine and Molecular Imaging
Purpose In this phase I study, we evaluated the safety, biodistribution and dosimetry of [89Zr]Zr-DFO-girentuximab (89Zr-girentuximab) PET/CT imaging in patients with suspicion of clear cell renal cell carcinoma (ccRCC). Methods Ten eligible patients
Autor:
Annemarie Kip, Sandra Heskamp, Egbert Oosterwijk, Alfred Morgenstern, Peter F.A. Mulders, Robin I. J. Merkx, Michael Wheatcroft, Mark Rijpkema, Frank Bruchertseifer
Publikováno v:
Journal of Medical Imaging and Radiation Sciences. 50:S95